• 四川大學(xué)華西醫(yī)院感染性疾病中心,生物治療國家重點實驗室感染性疾病研究室,四川成都 610041;

目的:建立能表達乙肝病毒(hepatitis B virus,HBV)preS2S抗原蛋白的荷瘤小鼠模型,為研究HBV核酸疫苗的體內(nèi)CTL應(yīng)答及免疫治療作用提供簡便易行的研究模型。 方法:以免疫印跡法驗證SP2/0-S2S細(xì)胞中有HBV preS2S抗原的穩(wěn)定表達,將SP2/0-S2S細(xì)胞種植到BALB/c小鼠脅部皮下(荷瘤),觀察能否生長成瘤,以及成瘤的時間、腫瘤大小和荷瘤后小鼠的生存時間;以免疫組織化學(xué)法檢測小鼠腫瘤組織HBV preS2S抗原的表達。以不表達preS2S抗原蛋白的SP2/0-CMV細(xì)胞荷瘤小鼠作為陰性對照。結(jié)果:荷瘤后3天~1周,SP2/0-S2S細(xì)胞可在小鼠皮下形成實體腫瘤,成瘤率為100%,腫瘤細(xì)胞中有preS2S抗原表達,荷瘤后小鼠的平均生存時間為16±1天;與不表達preS2S抗原蛋白的SP2/0-CMV細(xì)胞荷瘤小鼠相比,成瘤率、成瘤時間、腫瘤大小及生存時間差異。結(jié)論:建立了能表達HBV preS2S抗原蛋白的荷瘤小鼠模型,可用于HBV核酸疫苗的體內(nèi)CTL應(yīng)答及免疫治療作用的實驗研究。同時也建立了不表達preS2S抗原蛋白的荷瘤小鼠模型,可用作陰性對照。

引用本文: 何芳,唐紅,劉麗,劉聰,趙連三. 表達乙肝病毒preS2S蛋白的荷瘤小鼠模型的建立. 華西醫(yī)學(xué), 2008, 23(1): 96-98. doi: 復(fù)制

1. Li X,Yang X,Li L,et al.A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine[J].Vaccine,2006,24(16):3321-3331..
2. Xu W,Chu Y,Zhang R,et al.Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine[J].Virology,2005,334(2):255-263..
3. Xing YP,Huang ZH,Wang SX,et al.Novel DNA vaccine based on hepatitis B virus core gene induces specific immune responses in Balb/c mice[J].World J Gastroenterol,2005,11(29):4583-4586..
4. 何芳,秦山,趙連三,等.乙型肝炎病毒表面抗原M蛋白真核表達細(xì)胞株的建立及其表達產(chǎn)物的檢測[J].中國免疫學(xué)雜志,2001,17(5):236-243..
5. Ausubel FM,Brent R,Kingston RE,et al. Short protocols in molecular biology[M].3rd edition.Published by John Wiley & Sons,Inc.,USA.1995:10~1-10~48..
6. Tokushige K,Wakita T,Pachuk C,et al.Expression and Immune Response to Hepatitis C Virus Core DNA-Based Vaccine Constructs[J].Hepatology,1996,24:14-20..
7. Chisari FV,Ferrai C.Cytotoxic T cells and viral hepatitis[J].J Clin Invest,1997,99:1472-1477..
  1. 1. Li X,Yang X,Li L,et al.A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine[J].Vaccine,2006,24(16):3321-3331..
  2. 2. Xu W,Chu Y,Zhang R,et al.Endoplasmic reticulum targeting sequence enhances HBV-specific cytotoxic T lymphocytes induced by a CTL epitope-based DNA vaccine[J].Virology,2005,334(2):255-263..
  3. 3. Xing YP,Huang ZH,Wang SX,et al.Novel DNA vaccine based on hepatitis B virus core gene induces specific immune responses in Balb/c mice[J].World J Gastroenterol,2005,11(29):4583-4586..
  4. 4. 何芳,秦山,趙連三,等.乙型肝炎病毒表面抗原M蛋白真核表達細(xì)胞株的建立及其表達產(chǎn)物的檢測[J].中國免疫學(xué)雜志,2001,17(5):236-243..
  5. 5. Ausubel FM,Brent R,Kingston RE,et al. Short protocols in molecular biology[M].3rd edition.Published by John Wiley & Sons,Inc.,USA.1995:10~1-10~48..
  6. 6. Tokushige K,Wakita T,Pachuk C,et al.Expression and Immune Response to Hepatitis C Virus Core DNA-Based Vaccine Constructs[J].Hepatology,1996,24:14-20..
  7. 7. Chisari FV,Ferrai C.Cytotoxic T cells and viral hepatitis[J].J Clin Invest,1997,99:1472-1477..